CME Group Inc. $CME Shares Bought by Composition Wealth LLC

Composition Wealth LLC lifted its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 70.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,526 shares of the financial services provider’s stock after buying an additional 5,573 shares during the quarter. Composition Wealth LLC’s holdings in CME Group were worth $3,543,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Voya Investment Management LLC grew its position in shares of CME Group by 515.8% during the 3rd quarter. Voya Investment Management LLC now owns 766,090 shares of the financial services provider’s stock worth $200,522,000 after buying an additional 641,679 shares during the period. Bogart Wealth LLC raised its position in shares of CME Group by 1.5% in the 3rd quarter. Bogart Wealth LLC now owns 75,564 shares of the financial services provider’s stock valued at $19,796,000 after acquiring an additional 1,148 shares during the period. Public Sector Pension Investment Board raised its position in shares of CME Group by 16.8% in the 3rd quarter. Public Sector Pension Investment Board now owns 215,185 shares of the financial services provider’s stock valued at $59,937,000 after acquiring an additional 31,014 shares during the period. Global Retirement Partners LLC boosted its stake in CME Group by 3.3% during the 3rd quarter. Global Retirement Partners LLC now owns 10,902 shares of the financial services provider’s stock worth $2,856,000 after acquiring an additional 344 shares during the last quarter. Finally, South Dakota Investment Council boosted its stake in CME Group by 27.3% during the 3rd quarter. South Dakota Investment Council now owns 6,157 shares of the financial services provider’s stock worth $1,613,000 after acquiring an additional 1,319 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CME Group news, Director Daniel Kaye sold 532 shares of the company’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $304.17, for a total value of $161,818.44. Following the transaction, the director directly owned 4,313 shares of the company’s stock, valued at $1,311,885.21. This represents a 10.98% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Terrence Duffy sold 27,000 shares of the stock in a transaction on Wednesday, November 18th. The stock was sold at an average price of $309.57, for a total value of $8,358,390.00. Following the transaction, the chief executive officer owned 35,442 shares in the company, valued at $10,971,779.94. The trade was a 43.24% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 61,166 shares of company stock worth $18,276,512 over the last three months. 0.30% of the stock is currently owned by corporate insiders.

Key CME Group News

These are some of the CME news items that stood out recently:

  • Neutral Sentiment: Several reports focus on CME Group’s LPGA Tour Championship sponsorship and tournament coverage. This may support brand visibility, but no direct near-term financial impact was reported. Article
  • Negative Sentiment: Duffy sold 27,000 shares for about $8.36 million, reducing his direct stake by 43.24%. General Counsel John Clifford Marchese also sold 655 shares, an 18.20% reduction in his holdings. Insider sales can be made for personal reasons and do not necessarily signal a change in company outlook, but the CEO’s sale may weigh on sentiment. CEO filing General counsel filing
  • Negative Sentiment: A valuation-focused report says CME shares may be fully valued after a 69% run, raising the risk that expectations are already reflected in the price. Article

Analyst Upgrades and Downgrades

A number of research firms recently commented on CME. Piper Sandler restated an “overweight” rating and issued a $330.00 price objective (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. Wall Street Zen raised CME Group from a “sell” rating to a “hold” rating in a research note on Saturday, October 31st. Weiss Ratings upgraded CME Group from a “buy (b)” rating to a “buy (b+)” rating in a report on Friday, November 13th. Morgan Stanley raised their price target on CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Finally, TD Cowen lifted their price objective on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a report on Monday, October 5th. Ten investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, CME Group currently has an average rating of “Hold” and a consensus price target of $314.44.

Read Our Latest Stock Report on CME

CME Group Stock Performance

Shares of CME stock opened at $306.31 on Friday. The company’s fifty day simple moving average is $288.79 and its 200-day simple moving average is $282.00. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $109.64 billion, a PE ratio of 25.13, a P/E/G ratio of 3.79 and a beta of 0.15. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.71 billion. During the same quarter in the prior year, the business posted $2.68 EPS. The business’s revenue was up 10.6% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 12.35 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be paid a $1.30 dividend. The ex-dividend date is Friday, December 11th. This represents a $5.20 annualized dividend and a yield of 1.7%. CME Group’s payout ratio is 42.66%.

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.